Twin Tree Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,827
Closed -$3.19M 1778
2022
Q2
$2.93M Buy
+11,827
New +$3.19M ﹤0.01% 1000
2021
Q4
Sell
-9,291
Closed -$3.02M 1911
2021
Q3
$3.02M Sell
9,291
-11,051
-54% -$3.74M 0.01% 927
2021
Q2
$6.35M Buy
20,342
+19,179
+1,649% +$5.88M 0.02% 644
2021
Q1
$371K Buy
+1,163
New +$372K ﹤0.01% 1097
2020
Q3
Sell
-1,267
Closed -$306K 1678
2020
Q2
$306K Buy
+1,267
New +$254K ﹤0.01% 1210
2020
Q1
Sell
-3,357
Closed -$573K 1687
2019
Q4
$573K Buy
+3,357
New +$622K ﹤0.01% 954
2019
Q3
Sell
-16,491
Closed -$4.3M 1583
2019
Q2
$4.3M Sell
16,491
-17,561
-52% -$4.66M 0.02% 494
2019
Q1
$9.72M Buy
34,052
+19,434
+133% +$6.46M 0.05% 298
2018
Q4
$4.75M Buy
14,618
+10,504
+255% +$3.65M 0.03% 509
2018
Q3
$1.85M Buy
+4,114
New +$1.62M 0.01% 601
2017
Q1
Sell
-4,534
Closed -$511K 1334
2016
Q4
$511K Buy
+4,534
New +$525K 0.01% 887

Other funds holding ABMD

Twin Tree Management's ABMD Position: Q3 2022 in Review

Twin Tree Management sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 11,827 shares — an estimated $3.19M sold.

Twin Tree Management first reported a position in ABMD in Q4 2016 and held it in 11 quarters. The position peaked at $9.72M in Q1 2019. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Twin Tree Management reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Twin Tree Management sold 11,827 Abiomed Inc shares in Q3 2022, an estimated $3.19M.
  • Twin Tree Management first reported a position in Abiomed Inc in Q4 2016 and held it in 11 quarters.
  • Twin Tree Management's Abiomed Inc position peaked at $9.72M in Q1 2019.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Twin Tree Management's 13F filing for Q3 2022, filed 10 Nov 2022.